Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.930
+0.070 (1.44%)
At close: May 8, 2026, 4:00 PM EDT
4.950
+0.020 (0.41%)
After-hours: May 8, 2026, 7:06 PM EDT
Aclaris Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$11.33
Upside
+129.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $11 | Buy | Maintains | $7 → $11 | +123.12% | May 5, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +143.41% | May 5, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +102.84% | Apr 29, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +102.84% | Apr 16, 2026 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +62.27% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +224.54% | Mar 19, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +224.54% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +224.54% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +224.54% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $6 | Buy | Initiates | $6 | +21.70% | Jul 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +224.54% | Jun 25, 2025 |
| Wedbush | Wedbush | Buy Initiates $8 | Buy | Initiates | $8 | +62.27% | May 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +224.54% | May 14, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | +82.56% | May 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $15 | Buy | Initiates | $15 | +204.26% | Mar 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.